Non –risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary

Conclusions NRAS is an attractive management option for men with CSITC, which maintains outstanding long-term cancer cure while sparing most patients treatment by avoiding prophylactic chemotherapy, radiation, or surgery. Patient summary Men with clinically localized (stage I) testicular cancer have an excellent prognosis, regardless of management. Non–risk-adapted active surveillance is an attractive management option where only patients destined to relapse will receive any treatment following orchiectomy. However, individual patient preferences should be discussed in selecting a management strategy. Men with clinically localized, stage I testicular cancer have an excellent prognosis, regardless of management. Non–risk-adapted active surveillance is an attractive management option for men with clinical stage I testicular cancer, which offers outstanding long-term cancer cure while sparing most patients treatment by avoiding prophylactic chemotherapy, radiation, or surgery. Individual patient preferences and consideration of long-term toxicities should be discussed in selecting a management strategy.
Source: European Urology - Category: Urology & Nephrology Source Type: research